ENDRA LIFE SCIENCES INC. Finance Lease, Right-of-Use Asset, Amortization
ENDRA LIFE SCIENCES INC. (NDRA) reported Finance Lease, Right-of-Use Asset, Amortization of $505.82 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2023-03-16
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for the quarter ending 2022-12-31 was -$35.64K.
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for the quarter ending 2022-09-30 was -$34.80K.
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for the quarter ending 2022-06-30 was -$33.98K, a 108.80% decline year-over-year.
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for the quarter ending 2022-03-31 was $610.23K, a 89.77% increase year-over-year.
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $505.82K, a 21.39% decline from fiscal 2021.
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for fiscal 2021 was $643.41K, a 89.79% increase from fiscal 2020.
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for fiscal 2020 was $339.01K, a 884.53% increase from fiscal 2019.
- ENDRA LIFE SCIENCES INC. finance lease, right-of-use asset, amortization for fiscal 2019 was $34.43K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -$35.64K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$70.44K derived: sum of 2 quarters · filed 2023-03-16 | -$104.42K derived: sum of 3 quarters · filed 2023-03-16 | $505.82K 10-K · filed 2023-03-16 | |
| 2022-09-30 | -$34.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$68.78K derived: sum of 2 quarters · filed 2022-11-14 | $541.46K 10-Q · filed 2022-11-14 | $509.05K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2022-06-30 | -$33.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $576.25K 10-Q · filed 2022-08-15 | $543.85K derived: sum of 3 quarters · filed 2023-03-16 | $512.16K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2022-03-31 | $610.23K 10-Q · filed 2022-05-12 | $577.83K derived: sum of 2 quarters · filed 2023-03-16 | $546.14K derived: sum of 3 quarters · filed 2023-03-16 | $932.08K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-12-31 | -$32.41K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$64.09K derived: sum of 2 quarters · filed 2023-03-16 | $321.85K derived: sum of 3 quarters · filed 2023-03-16 | $643.41K 10-K · filed 2023-03-16 | |
| 2021-09-30 | -$31.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $354.26K derived: sum of 2 quarters · filed 2022-11-14 | $675.82K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $385.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $707.50K 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $321.56K 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $339.01K 10-K · filed 2022-03-30 | $65.91K 10-K · filed 2021-03-25 | |||
| 2019-12-31 | $34.43K 10-K · filed 2021-03-25 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |